• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Officer Munson Kelly T. was granted 17,742 shares, increasing direct ownership by 14% to 142,925 units (SEC Form 4)

    2/27/25 4:05:05 PM ET
    $DNOW
    Metal Fabrications
    Industrials
    Get the next $DNOW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Munson Kelly T.

    (Last) (First) (Middle)
    7402 NORTH ELDRIDGE PARKWAY

    (Street)
    HOUSTON TX 77041

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    DNOW Inc. [ DNOW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    See Remarks
    3. Date of Earliest Transaction (Month/Day/Year)
    02/25/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common stock 02/25/2025 A 17,742 A $0 142,925 D
    Common stock 156 I By 401k
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Chief Administrative & Information Officer
    /s/ Raymond W. Chang, as attorney-in-fact 02/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DNOW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DNOW

    DatePrice TargetRatingAnalyst
    7/8/2022$13.00Buy
    The Benchmark Company
    11/4/2021$12.00Equal-Weight → Overweight
    Stephens & Co.
    7/16/2021$12.00Hold → Buy
    Stifel
    More analyst ratings

    $DNOW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Benchmark Company initiated coverage on Now with a new price target

      The Benchmark Company initiated coverage of Now with a rating of Buy and set a new price target of $13.00

      7/8/22 7:15:53 AM ET
      $DNOW
      Metal Fabrications
      Industrials
    • NOW upgraded by Stephens & Co. with a new price target

      Stephens & Co. upgraded NOW from Equal-Weight to Overweight and set a new price target of $12.00

      11/4/21 7:03:09 AM ET
      $DNOW
      Metal Fabrications
      Industrials
    • NOW upgraded by Stifel with a new price target

      Stifel upgraded NOW from Hold to Buy and set a new price target of $12.00

      7/16/21 4:55:30 AM ET
      $DNOW
      Metal Fabrications
      Industrials

    $DNOW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Coppinger Paul M was granted 10,156 shares, increasing direct ownership by 18% to 66,724 units (SEC Form 4)

      4 - DNOW Inc. (0001599617) (Issuer)

      5/23/25 4:01:10 PM ET
      $DNOW
      Metal Fabrications
      Industrials
    • Director Cobb Galen was granted 10,156 shares, increasing direct ownership by 10% to 110,472 units (SEC Form 4)

      4 - DNOW Inc. (0001599617) (Issuer)

      5/23/25 4:01:05 PM ET
      $DNOW
      Metal Fabrications
      Industrials
    • Director Eads Rodney W was granted 10,156 shares, increasing direct ownership by 10% to 115,736 units (SEC Form 4)

      4 - DNOW Inc. (0001599617) (Issuer)

      5/23/25 4:01:07 PM ET
      $DNOW
      Metal Fabrications
      Industrials

    $DNOW
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • December 15, 2023 - FDA Roundup: December 15, 2023

      For Immediate Release: December 15, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the breast implants web pages to share the latest information on: Risks and complications related to breast implants  Reports of squamous cell carcinoma (SCC), various lymphomas other than Breast Implants Associated Anaplastic Large

      12/15/23 3:14:20 PM ET
      $DNOW
      Metal Fabrications
      Industrials
    • October 24, 2023 - FDA Roundup: October 24, 2023

      For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Friday, the FDA approved Medtronic’s Aurora EV-ICD System for the treatment of patients who have experienced, or are at significant risk of developing, life-threatening abnormally fast heart rhythms (ventricular tachyarrhythmias). The system is composed of

      10/24/23 2:26:32 PM ET
      $DNOW
      Metal Fabrications
      Industrials
    • June 9, 2023 - FDA Roundup: June 9, 2023

      For Immediate Release: June 09, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA provided information to health care providers and facilities on oxygenator devices used in extracorporeal circulation. The FDA issued this letter to help ensure that health care providers and facilities are aware of a recall notice by Getinge/Maque

      6/9/23 3:24:13 PM ET
      $DNOW
      Metal Fabrications
      Industrials